期刊文献+

IGF1和IGF1R在甲状腺乳头状癌组织中的表达 被引量:4

Action of IGF1 and IGF1R in thyroid papillary carcinoma
暂未订购
导出
摘要 目的:探索胰岛素样生长因子-1(IGF1)及其受体(IGF1R)在甲状腺乳头状癌发生、发展中的作用,寻找新的甲状腺乳头状癌诊断标志物,并为甲状腺乳头状癌的病因研究寻找新的理论依据。方法:以15例正常人甲状腺组织标本作对照,对62例经手术切除并由病理证实的甲状腺乳头状癌患者的癌、癌旁及正常区组织标本进行研究,应用RT-PCR方法,检测IGF1/IGF1R在甲状腺癌组织与正常人甲状腺组织中的表达。结果:甲状腺乳头状癌组IGF1/IGF1RmRNA的表达量明显高于正常对照组(P<0.01)。甲状腺乳头状癌患者的癌、癌旁及正常区组织中IGF1/IGF1RmRNA的表达量按正常、癌旁、癌组织顺序逐渐增高(P<0.01)。结论:IGF1/IGF1R的高表达促进了甲状腺上皮细胞的异常增殖,提示IGF1/IGF1R可作为甲状腺乳头状癌诊断的标志物。 Objective: To study the role of insulin-like growth factorl and insulin-like growth factorl receptor (IGF1/IGF1R) in the carcinogenesis of thyroid papillary carcinoma. Methods: The mRNA levels of IGF1/IGF1R were assessed by RT- PCR method in thyroid cancer tissues, adjacent tissues and tumor free tissues of 62 patients with thyroid papillary carcinoma and in normal thyroid tissues of 15 healthy controls. Tissue specimens were obtained by biop- sy, and confirmed by histological evaluation. Results: The mRNA levels of IGF1/IGF1R increased in thyroid carcinoma tissues compared with normal tissues of healthy controls ( P 〈 0.01 ). There was a significant difference between thyroid cancer tissues and the tumor free tissues ( P 〈 0.01 ). The mRNA levels of IGF1/IGF1R increased from the tumor free tissues, adjacent tissues to the thyroid cancer tissues ( P 〈 0. 01 ). Conclusions: The high expression of IGF1/IGF1R acts greatly in the carcinogenesis and development of thyroid papillary carcinoma, and they might be used as indicators for early diagnosis of thyroid carcinoma.
作者 马宏岩 郭军
出处 《山东大学学报(医学版)》 CAS 北大核心 2006年第9期905-907,910,共4页 Journal of Shandong University:Health Sciences
关键词 甲状腺肿瘤 胰岛素样生长因子1 受体 胰岛素样生长因子1 Thyroid neoplasms Insulin-like growth factorl Receptor, insulin-like growth factorl
  • 相关文献

参考文献7

  • 1Garcia-Jimenz C, Zaballos MA, Santistebab P. DARPP-32 (dopamine and 3',5'-cyclic adenosine monophosphate-regulated neuronal phosphoprotein) is essential for the maintenance of thyroid differentiation [J]. Mol Endocrinol, 2005,19(12) :3 060-3 072.
  • 2Tita P, Ambrosio MR, Scollo C, et al. High prevalence of differentiated thyroid carcinoma in acromegaly[J]. Clin Endocrinol(Oxf), 2005, 63(2) : 161-167.
  • 3Siegle G, Tomer Y. Is there an association between acromegaly and thyroid carcinoma? A critical review of the literature [J]. Endocr Res, 2005, 31(1):51-58.
  • 4Isozaki O. Mechanism of abnormal thyroid cell proliferation in normal and tumor tissues [J]. Nippon Rinsho, 2005, 63(Suppl 10) : 153-158.
  • 5Ciampolillo A, De Tullio C, Giorgino F. The IGF-I/IGF-I receptor pathway: Implications in the Pathophysiology of Thyroid Cancer[J]. Curt Med Chem, 2005, 12(24):2 881-2 891.
  • 6Wasko R, Michalek K, Pacholska J, et al. Clinical significance of the insulin-like growth factor Ⅰ gene promoter (P1) polymorphism in thyroid nodular disease[J]. Neuro Endoerinol Lett, 2005, 26(6) :699-703.
  • 7Marchisotti FG, Umeda LM, Zach PL, et al. Acromegaly and thyroid disease: prevalence of thyroid cancer [J]. Arq Bras Endocrinol Metabol, 2005, 49(5):843-849.

同被引文献50

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部